Skip to main content

MSF at the 48th Union World Conference on Lung Health

War in Gaza:: find out how we're responding
Learn more

The 48th Union World Conference on Lung Health takes place in Guadalajara, Mexico, on 11-14 October 2017. Follow on social media using the hashtag: #UnionConf

msf-union-world-conference-lung-health-2017.pdf pdf — 205.58 KB Download

Briefing Documents

Issue Brief: Four Years and Counting

This issue brief examines current opportunities to optimise MDR-TB treatment and to address the persistent access challenges that put treatment out of reach for people struggling to survive this deadly disease.

Press Releases & News Updates

This section will be updated as news is released.

MSF Abstracts

Delamanid for rifampicin-resistant tuberculosis: an observational cohort study from Khayelitsha, South Africa 
[A-911-0005-00762]
Presenters: Erika Mohr, Jennifer Hughes, Anja Reuter, Gabriella Ferlazzo, Virginia De Avezedo, Amir Shroufi, Serge Ade, Petros Isaakidis.

Adverse events over 6 months with delamanid in a programmatic setting in Khayelitsha, South Africa
[A-911-0005-01541]
Presenters: Jennifer Hughes, Anja Reuter, Bongani Chabalala, Laura Trivino Duran, Gabriella Ferlazzo, Helen Cox, Erika Mohr.

Accelerating access to delamanid for rifampicin-resistant tuberculosis in Khayelitsha, South Africa
[A-911-0005-01579]
Presenters: Jennifer Hughes, Laura Trivino, Chantal Fourie, Vanessa Mudaly, Anja Reuter, Gabriella Ferlazzo, Vivian Cox, Jennifer Furin.

Up Next
Tuberculosis
Press Release 23 March 2017